Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42

AbbVie reports Q1 adjusted EPS $2.14, consensus $2.06

Reports Q1 revenue $7.83B, consensus $7.76B.

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABBV AbbVie
$78.71

0.06 (0.08%)

03/25/19
ARGS
03/25/19
DOWNGRADE
ARGS
Hold
AbbVie downgraded to Hold from Buy at Argus
03/25/19
03/25/19
DOWNGRADE

Hold
AbbVie downgraded to Hold from Buy at Argus
As previously reported, Argus analyst David Toung downgraded AbbVie to Hold, saying its flagship program Humira "no longer looks invulnerable to competition from biosimilars in Europe and other overseas markets." The analyst notes that Humira is also faced with "indirect competition from newer drugs that have an alternative mechanism of action" compared to Humira's anti-TNF class. Toung further cites AbbVie's clinical setback with Venclexta, which highlights the risks for the company as it develops a pipeline aimed to offset the expected decline in Humira sales.
03/26/19
WBLR
03/26/19
UPGRADE
WBLR
Outperform
William Blair upgrades Vertex to Outperform after 'subpar' competitor data
William Blair analyst Y. Katherine Xu upgraded Vertex Pharmaceuticals (VRTX) to Outperform from Market Perform on expectations the company's cystic fibrosis franchise will continue dominating after Proteostasis (PTI) reported disappointing triplet data. Proteostasis' triplet efficacy falls short of the high bar set by the Vertex triples, Xu tells investors in a research note. While Proteostasis is starting a Phase II study of the triplet that would include a higher PTI-808 dose and test a longer duration aiming to optimize response with data out around year-end 2019, the chance of it matching or exceeding Vertex triple efficacy is "very low," contends the analyst. With both Galapagos (GLPG)/AbbVie (ABB) and Proteostasis having shown "subpar data," Xu is upgrading Vertex shares to Outperform and raised her fair value estimate for the shares to $222 from $178. The analyst maintains her high probability of success of a Vertex triple combo reaching the cystic fibrosis market at 90% and ascribe peak sales of $10.2B, up from $8.9 billion previously.
04/11/19
EVER
04/11/19
INITIATION
Target $30
EVER
Outperform
Myovant Sciences initiated with an Outperform at Evercore ISI
Evercore ISI analyst Ravi Mehrotra initiated Myovant Sciences (MYOV) with an Outperform rating and a price targets of $30. The analyst says the company's lead program relugolix has been clinically de-risked with near-term pivotal data readouts. Mehrotra is modeling revenues of $944M for the program by 2023 thanks to its "commercial advantage of a one-a-day pill" and the "second-mover leverage of competitor AbbVie's (ABBV) efforts to raise awareness and diagnosis" in woman's health market.

TODAY'S FREE FLY STORIES

15:20
06/19/19
06/19
15:20
06/19/19
15:20
General news
More Powell: there was talk about raising the inflation goal to 4% »

More Powell: there was…

SCS

Steelcase

$17.74

0.18 (1.03%)

15:19
06/19/19
06/19
15:19
06/19/19
15:19
Options
Steelcase options imply 11.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 24

    Jun

  • 26

    Jun

  • 10

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
06/19/19
06/19
15:17
06/19/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
06/19/19
06/19
15:16
06/19/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.86

0.53 (0.18%)

, SPX

S&P 500

$0.00

(0.00%)

15:14
06/19/19
06/19
15:14
06/19/19
15:14
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell says FOMC…

SPY

SPDR S&P 500 ETF Trust

$292.86

0.53 (0.18%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.81

0.48 (0.16%)

, SPX

S&P 500

$0.00

(0.00%)

15:13
06/19/19
06/19
15:13
06/19/19
15:13
General news
Powell says labor market 'in a good place' »

Fed Chair Powell said…

SPY

SPDR S&P 500 ETF Trust

$292.81

0.48 (0.16%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:10
06/19/19
06/19
15:10
06/19/19
15:10
General news
Powell: there was not much support for cutting rates now »

Powell: there was not…

FB

Facebook

$185.40

-3.06 (-1.62%)

, SPY

SPDR S&P 500 ETF Trust

$292.52

0.19 (0.06%)

15:04
06/19/19
06/19
15:04
06/19/19
15:04
General news
Powell says 'a long way' from digital currencies replacing traditional currency »

Facebook (FB) has…

FB

Facebook

$185.40

-3.06 (-1.62%)

SPY

SPDR S&P 500 ETF Trust

$292.52

0.19 (0.06%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 10

    Jul

AOBC

American Outdoor Brands

$9.05

0.01 (0.11%)

15:04
06/19/19
06/19
15:04
06/19/19
15:04
Options
American Outdoor Brands options imply 17.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

SPY

SPDR S&P 500 ETF Trust

$292.70

0.37 (0.13%)

, SPX

S&P 500

$0.00

(0.00%)

14:59
06/19/19
06/19
14:59
06/19/19
14:59
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell says 'we have…

SPY

SPDR S&P 500 ETF Trust

$292.70

0.37 (0.13%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$197.66

-0.86 (-0.43%)

, GS

Goldman Sachs

$195.44

0.455 (0.23%)

14:58
06/19/19
06/19
14:58
06/19/19
14:58
Periodicals
Apple expanding credit card test to thousands of retail workers, Bloomberg says »

Apple (AAPL) is ramping…

AAPL

Apple

$197.66

-0.86 (-0.43%)

GS

Goldman Sachs

$195.44

0.455 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 09

    Jul

  • 16

    Jul

RRGB

Red Robin

$31.03

-0.96 (-3.00%)

14:55
06/19/19
06/19
14:55
06/19/19
14:55
Hot Stocks
Red Robin says will review Vintage Capital request for special meeting »

In a filing, Red Robin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
06/19/19
06/19
14:55
06/19/19
14:55
General news
Powell: "i'm sure things will change before the next meeting," »

Powell: "i'm…

SPY

SPDR S&P 500 ETF Trust

$292.78

0.45 (0.15%)

, SPX

S&P 500

$0.00

(0.00%)

14:54
06/19/19
06/19
14:54
06/19/19
14:54
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell says 'not…

SPY

SPDR S&P 500 ETF Trust

$292.78

0.45 (0.15%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$250.98

5.33 (2.17%)

, DVA

DaVita

$51.30

1.54 (3.09%)

14:52
06/19/19
06/19
14:52
06/19/19
14:52
Periodicals
FTC approves UnitedHealth acquisition of Davita Medical, Forbes says »

The Federal Trade…

UNH

UnitedHealth

$250.98

5.33 (2.17%)

DVA

DaVita

$51.30

1.54 (3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

RRGB

Red Robin

$31.09

-0.9 (-2.81%)

14:52
06/19/19
06/19
14:52
06/19/19
14:52
Hot Stocks
Red Robin shareholder calls for board shakeup »

Vintage Capital, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$293.09

0.76 (0.26%)

, SPX

S&P 500

$0.00

(0.00%)

14:51
06/19/19
06/19
14:51
06/19/19
14:51
General news
Powell says no talks yet on whether next cut would be 25 or 50 basis points »

Fed chair Powell said the…

SPY

SPDR S&P 500 ETF Trust

$293.09

0.76 (0.26%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$52.68

-0.2 (-0.38%)

14:49
06/19/19
06/19
14:49
06/19/19
14:49
Options
Oracle options imply 7.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

RF

Regions Financial

$14.60

-0.27 (-1.82%)

14:45
06/19/19
06/19
14:45
06/19/19
14:45
Options
Regions Financial call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

14:45
06/19/19
06/19
14:45
06/19/19
14:45
General news
Fed Chair Powell opened his presser noting "significant changes" »

Fed Chair Powell opened…

SPY

SPDR S&P 500 ETF Trust

$292.63

0.3 (0.10%)

, SPX

S&P 500

$0.00

(0.00%)

14:44
06/19/19
06/19
14:44
06/19/19
14:44
General news
Powell: Trade 'important driver of sentiment,' but Fed not focused on one thing »

Asked if a trade deal…

SPY

SPDR S&P 500 ETF Trust

$292.63

0.3 (0.10%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.64

0.31 (0.11%)

, SPX

S&P 500

$0.00

(0.00%)

14:43
06/19/19
06/19
14:43
06/19/19
14:43
General news
Powell says 'law is clear I have a 4-year term,' 'fully intend to serve it' »

Asked how he would react…

SPY

SPDR S&P 500 ETF Trust

$292.64

0.31 (0.11%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:42
06/19/19
06/19
14:42
06/19/19
14:42
Conference/Events
Stephens retail/broadlines analyst to hold a luncheon meeting »

Retail/Broadlines Analyst…

DIS

Disney

$140.09

0.88 (0.63%)

14:41
06/19/19
06/19
14:41
06/19/19
14:41
Periodicals
More layoffs from Disney and 20th Century Fox film divisions, Variety reports »

Matt Donelly and Brent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

SPY

SPDR S&P 500 ETF Trust

$292.48

0.15 (0.05%)

, SPX

S&P 500

$0.00

(0.00%)

14:40
06/19/19
06/19
14:40
06/19/19
14:40
General news
Powell says will be monitoring 'cross-currents,' but would 'like to see more' »

"Many" on the…

SPY

SPDR S&P 500 ETF Trust

$292.48

0.15 (0.05%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.